Skip to main content
Erschienen in: International Urology and Nephrology 4/2024

30.11.2023 | Urology - Review

Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan

verfasst von: Sheng-Fu Chen, Hann-Chorng Kuo

Erschienen in: International Urology and Nephrology | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

The main problems of neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury (SCI) consist of impaired urine storage, impaired bladder emptying, or both. The priorities in the management of SCI–NLUTD should be preservation of renal function, followed by freedom from urinary tract infections and improvement of quality of life. Management of NLUTD in patients with SCI must be based on urodynamic findings rather than clinical evaluations. In the hospital without urodynamic equipment, careful measurement of intravesical pressure and safety functional bladder capacity in conjunction with clinical assessment are also feasible. Identification of high-risk patients is important for preventing urological complications in patients with chronic SCI. The management of NLUTD should start with conservative bladder management and medical treatment. Patients with SCI should be regularly followed up, and any NLUTDs and urological complications should be adequately treated. When surgical intervention is necessary, less invasive and reversible procedures should be considered first, and any unnecessary surgery should be avoided. This article reports the current evidence and expert opinions on the patient-centered bladder management of NLUTD in chronic SCI patients in Taiwan. To avoid renal function deterioration and urological complications, annual active surveillance of bladder and renal function is mandatory, especially for high-risk SCI patients.
Literatur
1.
Zurück zum Zitat Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, Karsenty G, Kessler TM, Schneider M, 't Hoen L, Blok B (2016) Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol 69:324-333 Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, Karsenty G, Kessler TM, Schneider M, 't Hoen L, Blok B (2016) Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol 69:324-333
2.
Zurück zum Zitat Chen YJ, Lo SH, Meng E, Shen JD, Eric Chou CL, Chen SF, Lee MH, Hsu CY, Ong HL, Chen JT, Chen SL, Tsai YA, Lin CC, Wu SY, Chiu B, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury–Part 1: Pathophysiology, treatment strategy and priority. Urol Sci 34:3–9 Chen YJ, Lo SH, Meng E, Shen JD, Eric Chou CL, Chen SF, Lee MH, Hsu CY, Ong HL, Chen JT, Chen SL, Tsai YA, Lin CC, Wu SY, Chiu B, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury–Part 1: Pathophysiology, treatment strategy and priority. Urol Sci 34:3–9
3.
Zurück zum Zitat Chen SF, Kuo HC (2022) Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: a urologist’s perspective. Low Urin Tract Symp 14:132–139CrossRef Chen SF, Kuo HC (2022) Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: a urologist’s perspective. Low Urin Tract Symp 14:132–139CrossRef
4.
Zurück zum Zitat Chang TL, Kuo HC (2023) The videourodynamic characteristics of patients with chronic spinal cord injury with different injury levels and bladder conditions. Urol Sci 34:46–52 Chang TL, Kuo HC (2023) The videourodynamic characteristics of patients with chronic spinal cord injury with different injury levels and bladder conditions. Urol Sci 34:46–52
5.
Zurück zum Zitat Ong HL, Chiang IN, Hsu LN, Chin CW, Shao IH, Jang MY, Juan YS, Wang CC, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Conservative bladder management and medical treatment in chronic spinal cord injury patients. J Clin Med 12:2021PubMedPubMedCentralCrossRef Ong HL, Chiang IN, Hsu LN, Chin CW, Shao IH, Jang MY, Juan YS, Wang CC, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Conservative bladder management and medical treatment in chronic spinal cord injury patients. J Clin Med 12:2021PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Wu SY, Jhang JF, Liu HH, Chen JT, Li JR, Chiu B, Chen SL, Kuo HC (2023) Long-term surveillance and management of urological complications in chronic spinal cord-injured patients. J Clin Med 11:7307CrossRef Wu SY, Jhang JF, Liu HH, Chen JT, Li JR, Chiu B, Chen SL, Kuo HC (2023) Long-term surveillance and management of urological complications in chronic spinal cord-injured patients. J Clin Med 11:7307CrossRef
7.
Zurück zum Zitat Lin YH, Fan YH, Wu CT, Shen YC, Hu JC, Huang SW, Chow PM, Chang PC, Liao CH, Chen YC, Victor C. Lin, Hsu CC, Chang SJ, Wang CC, Lin WY, Lin CC, Jiang YH, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury – Part 3: Surgical treatment in chronic spinal cord injured patients. Urol Sci 34:109-116 Lin YH, Fan YH, Wu CT, Shen YC, Hu JC, Huang SW, Chow PM, Chang PC, Liao CH, Chen YC, Victor C. Lin, Hsu CC, Chang SJ, Wang CC, Lin WY, Lin CC, Jiang YH, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury – Part 3: Surgical treatment in chronic spinal cord injured patients. Urol Sci 34:109-116
8.
Zurück zum Zitat McGuire EJ, Cespedes RD, O’Connell HE (1996) Leak-point pressures. Urol Clin North Am 23:253–262PubMedCrossRef McGuire EJ, Cespedes RD, O’Connell HE (1996) Leak-point pressures. Urol Clin North Am 23:253–262PubMedCrossRef
9.
Zurück zum Zitat Stöhrer M, Goepel M, Kondo A, Kramer G, Madersbacher H, Millard R, Rossier A, Wyndaele JJ (1999) The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 18:139–158PubMedCrossRef Stöhrer M, Goepel M, Kondo A, Kramer G, Madersbacher H, Millard R, Rossier A, Wyndaele JJ (1999) The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 18:139–158PubMedCrossRef
10.
Zurück zum Zitat Madersbacher S, Pycha A, Klingler CH, Mian C, Djavan B, Stulnig T, Marberger M (1999) Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms. Neurourol Urodyn 18:3–15PubMedCrossRef Madersbacher S, Pycha A, Klingler CH, Mian C, Djavan B, Stulnig T, Marberger M (1999) Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms. Neurourol Urodyn 18:3–15PubMedCrossRef
11.
Zurück zum Zitat Weld KJ, Wall BM, Mangold TA, Steere EL, Dmochowski RR (2000) Influences on renal function in chronic spinal cord injured patients. J Urol 164:1490–1493PubMedCrossRef Weld KJ, Wall BM, Mangold TA, Steere EL, Dmochowski RR (2000) Influences on renal function in chronic spinal cord injured patients. J Urol 164:1490–1493PubMedCrossRef
12.
Zurück zum Zitat Mitsui T, Minami K, Furuno T, Morita H, Koyanagi T (2000) Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol 38:434–438PubMedCrossRef Mitsui T, Minami K, Furuno T, Morita H, Koyanagi T (2000) Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol 38:434–438PubMedCrossRef
13.
Zurück zum Zitat Weld KJ, Dmochowski RR (2000) Effect of bladder management on urological complications in spinal cord injured patients. J Urol 163:768–772PubMedCrossRef Weld KJ, Dmochowski RR (2000) Effect of bladder management on urological complications in spinal cord injured patients. J Urol 163:768–772PubMedCrossRef
14.
Zurück zum Zitat Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ (2010) Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol 184:213–217PubMedCrossRef Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ (2010) Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol 184:213–217PubMedCrossRef
15.
Zurück zum Zitat Chen SF, Jiang YH, Jhang JF, Lee CL, Kuo HC (2014) Bladder management and urological complications in patients with chronic SCI in Taiwan. Tzu Chi Med J 26:25–28CrossRef Chen SF, Jiang YH, Jhang JF, Lee CL, Kuo HC (2014) Bladder management and urological complications in patients with chronic SCI in Taiwan. Tzu Chi Med J 26:25–28CrossRef
16.
Zurück zum Zitat Ginsberg DA, Boone TB, Cameron AP, Gousse A, Kaufman MR, Keays E, Kennelly MJ, Lemack GE, Rovner ES, Souter LH, Yang CC, Kraus SR (2021) The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J Urol 206:1106–1113PubMedCrossRef Ginsberg DA, Boone TB, Cameron AP, Gousse A, Kaufman MR, Keays E, Kennelly MJ, Lemack GE, Rovner ES, Souter LH, Yang CC, Kraus SR (2021) The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: treatment and follow-up. J Urol 206:1106–1113PubMedCrossRef
17.
Zurück zum Zitat Zhang D, Sun F, Yao H, Bao X, Wang D, Cui Y, Wu J (2021) The efficacy and safety of mirabegron for the treatment of neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis. Front Pharmacol 12:756582PubMedPubMedCentralCrossRef Zhang D, Sun F, Yao H, Bao X, Wang D, Cui Y, Wu J (2021) The efficacy and safety of mirabegron for the treatment of neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis. Front Pharmacol 12:756582PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Reitz A, Haferkamp A, Kyburz T, Knapp PA, Wefer B, Schurch B (2004) The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women. Eur Urol 46:235–240PubMedCrossRef Reitz A, Haferkamp A, Kyburz T, Knapp PA, Wefer B, Schurch B (2004) The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women. Eur Urol 46:235–240PubMedCrossRef
19.
Zurück zum Zitat Diokno AC, Koppenhoefer R (1976) Bethanechol chloride in neurogenic bladder dysfunction. Urology 8:455–458PubMedCrossRef Diokno AC, Koppenhoefer R (1976) Bethanechol chloride in neurogenic bladder dysfunction. Urology 8:455–458PubMedCrossRef
20.
Zurück zum Zitat Light JK, Scott FB (1982) Bethanechol chloride and the traumatic cord bladder. J Urol 128:85–87PubMedCrossRef Light JK, Scott FB (1982) Bethanechol chloride and the traumatic cord bladder. J Urol 128:85–87PubMedCrossRef
21.
Zurück zum Zitat Mangera A, Apostolidis A, Andersson KE, Dasgupta P, Giannantoni A, Roehrborn C, Novara G, Chapple C (2014) An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol 65:981–990PubMedCrossRef Mangera A, Apostolidis A, Andersson KE, Dasgupta P, Giannantoni A, Roehrborn C, Novara G, Chapple C (2014) An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol 65:981–990PubMedCrossRef
22.
Zurück zum Zitat Dykstra DD, Sidi AA (1990) Treatment of detrusor-sphincter dyssynergia with botulinum a toxin: a double-blind study. Arch Phys Med Rehabil 71:24–26PubMed Dykstra DD, Sidi AA (1990) Treatment of detrusor-sphincter dyssynergia with botulinum a toxin: a double-blind study. Arch Phys Med Rehabil 71:24–26PubMed
23.
Zurück zum Zitat Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 2:519–533 Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 2:519–533
24.
Zurück zum Zitat Kuo HC (2003) Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 170:1908–1912PubMedCrossRef Kuo HC (2003) Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 170:1908–1912PubMedCrossRef
25.
Zurück zum Zitat Kuo HC, Liu HT, Chuang YC, Birder LA, Chancellor MB (2014) Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study. Eur Urol 65:1117–1124PubMedCrossRef Kuo HC, Liu HT, Chuang YC, Birder LA, Chancellor MB (2014) Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study. Eur Urol 65:1117–1124PubMedCrossRef
26.
Zurück zum Zitat Chen SF, Kuo HC (2021) Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury? Tzu Chi Med J 33:101–107PubMedCrossRef Chen SF, Kuo HC (2021) Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury? Tzu Chi Med J 33:101–107PubMedCrossRef
27.
Zurück zum Zitat Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF, Botox Detrusor Hyperreflexia Study Team (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174:196–200PubMedCrossRef Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF, Botox Detrusor Hyperreflexia Study Team (2005) Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174:196–200PubMedCrossRef
28.
Zurück zum Zitat Kuo HC, Liu SH (2011) Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries. Neurourol Urodyn 30:1541–1545PubMedCrossRef Kuo HC, Liu SH (2011) Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries. Neurourol Urodyn 30:1541–1545PubMedCrossRef
29.
Zurück zum Zitat Chen YC, Kuo HC (2014) The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients. Neurourol Urodyn 33:129–134PubMedCrossRef Chen YC, Kuo HC (2014) The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients. Neurourol Urodyn 33:129–134PubMedCrossRef
30.
Zurück zum Zitat Chen CY, Liao CH, Kuo HC (2011) Therapeutic effects of detrusor botulinum toxin a injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia. Spinal Cord 49:659–664PubMedCrossRef Chen CY, Liao CH, Kuo HC (2011) Therapeutic effects of detrusor botulinum toxin a injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia. Spinal Cord 49:659–664PubMedCrossRef
31.
Zurück zum Zitat Kuo HC (2006) Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology 67:232–236PubMedCrossRef Kuo HC (2006) Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology 67:232–236PubMedCrossRef
32.
Zurück zum Zitat Grosse J, Kramer G, Stöhrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653–659PubMedCrossRef Grosse J, Kramer G, Stöhrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653–659PubMedCrossRef
33.
Zurück zum Zitat Kuo HC (2008) Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection. Urology 72:1056–1060PubMedCrossRef Kuo HC (2008) Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection. Urology 72:1056–1060PubMedCrossRef
34.
Zurück zum Zitat Chen SF, Kuo HC (2015) Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity. J Formos Med Assoc 114:583–589PubMedCrossRef Chen SF, Kuo HC (2015) Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity. J Formos Med Assoc 114:583–589PubMedCrossRef
35.
Zurück zum Zitat Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW, 191622-096 Investigators (2017) Long-term treatment with onabotulinumtoxinA results in consistent, durable improvements in health related quality of life in patients with overactive bladder. J Urol 198:897–904PubMedCrossRef Ginsberg DA, Drake MJ, Kaufmann A, Radomski S, Gousse AE, Chermansky CJ, Magyar A, Nicandro JP, Nitti VW, 191622-096 Investigators (2017) Long-term treatment with onabotulinumtoxinA results in consistent, durable improvements in health related quality of life in patients with overactive bladder. J Urol 198:897–904PubMedCrossRef
36.
Zurück zum Zitat Chen PY, Cheng JH, Wu ZS, Chuang YC (2022) New Frontiers of extracorporeal shock wave medicine in urology from bench to clinical studies. Biomedicines 10:675PubMedPubMedCentralCrossRef Chen PY, Cheng JH, Wu ZS, Chuang YC (2022) New Frontiers of extracorporeal shock wave medicine in urology from bench to clinical studies. Biomedicines 10:675PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Smith CP, Nishiguchi J, O’Leary M, Yoshimura N, Chancellor MB (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65:37–41PubMedCrossRef Smith CP, Nishiguchi J, O’Leary M, Yoshimura N, Chancellor MB (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65:37–41PubMedCrossRef
38.
Zurück zum Zitat Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, Yoshimura N, Chancellor MB (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165:1107–1110PubMedCrossRef Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, Yoshimura N, Chancellor MB (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165:1107–1110PubMedCrossRef
39.
Zurück zum Zitat Kuo HC (2013) Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia. Int J Clin Pract 67:1044–1049PubMedCrossRef Kuo HC (2013) Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia. Int J Clin Pract 67:1044–1049PubMedCrossRef
40.
Zurück zum Zitat Elkelini MS, Bagli DJ, Fehlings M, Hassouna M (2012) Effects of intravesical onabotulinumtoxinA on bladder dysfunction and autonomic dysreflexia after spinal cord injury: role of nerve growth factor. BJU Int 109:402–407PubMedCrossRef Elkelini MS, Bagli DJ, Fehlings M, Hassouna M (2012) Effects of intravesical onabotulinumtoxinA on bladder dysfunction and autonomic dysreflexia after spinal cord injury: role of nerve growth factor. BJU Int 109:402–407PubMedCrossRef
41.
Zurück zum Zitat Fougere RJ, Currie KD, Nigro MK, Stothers L, Rapoport D, Krassioukov AV (2016) Reduction in bladder-related autonomic dysreflexia after onabotulinumtoxinA treatment in spinal cord injury. J Neurotrauma 33:1651–1657PubMedPubMedCentralCrossRef Fougere RJ, Currie KD, Nigro MK, Stothers L, Rapoport D, Krassioukov AV (2016) Reduction in bladder-related autonomic dysreflexia after onabotulinumtoxinA treatment in spinal cord injury. J Neurotrauma 33:1651–1657PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Tow AM, Toh KL, Chan SP, Consigliere D (2007) Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore. Ann Acad Med Singap 36:11–17PubMedCrossRef Tow AM, Toh KL, Chan SP, Consigliere D (2007) Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore. Ann Acad Med Singap 36:11–17PubMedCrossRef
43.
Zurück zum Zitat Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C (2011) Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60:742–750PubMedCrossRef Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C (2011) Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60:742–750PubMedCrossRef
44.
Zurück zum Zitat Jaggi A, Drake M, Siddiqui E, Fatoye F (2018) A comparison of the treatment recommendations for neurogenic lower urinary tract dysfunction in the national institute for health and care excellence, European association of urology and international consultations on incontinence guidelines. Neurourol Urodyn 37:2273–2280PubMedCrossRef Jaggi A, Drake M, Siddiqui E, Fatoye F (2018) A comparison of the treatment recommendations for neurogenic lower urinary tract dysfunction in the national institute for health and care excellence, European association of urology and international consultations on incontinence guidelines. Neurourol Urodyn 37:2273–2280PubMedCrossRef
45.
Zurück zum Zitat Kao YL, Chen JT, Chen SL, Shao IH, Wang CC, Chiang IN, Hsu YC, Lee KH, Lee WC, Yeh TC, Kuo YC, Chiang BJ, Liao CH, Chen PC, Meng E, Lee YC, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury — Part 2: Conservative and minimally invasive treatment. Urol Sci 34:10–17 Kao YL, Chen JT, Chen SL, Shao IH, Wang CC, Chiang IN, Hsu YC, Lee KH, Lee WC, Yeh TC, Kuo YC, Chiang BJ, Liao CH, Chen PC, Meng E, Lee YC, Kuo HC, Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury — Part 2: Conservative and minimally invasive treatment. Urol Sci 34:10–17
46.
Zurück zum Zitat Wu SY, Kuo HC (2018) A real-world experience with augmentation enterocystoplasty-High patient satisfaction with high complication rates. Neurourol Urodyn 37:744–750PubMedCrossRef Wu SY, Kuo HC (2018) A real-world experience with augmentation enterocystoplasty-High patient satisfaction with high complication rates. Neurourol Urodyn 37:744–750PubMedCrossRef
47.
Zurück zum Zitat Perkash I (1978) Detrusor-sphincter dyssynergia and dyssynergic responses: recognition and rationale for early modified transurethral sphincterotomy in complete spinal cord injury lesions. J Urol 120:469–474PubMedCrossRef Perkash I (1978) Detrusor-sphincter dyssynergia and dyssynergic responses: recognition and rationale for early modified transurethral sphincterotomy in complete spinal cord injury lesions. J Urol 120:469–474PubMedCrossRef
48.
Zurück zum Zitat Pan D, Troy A, Rogerson J, Bolton D, Brown D, Lawrentschuk N (2009) Long-term outcomes of external sphincterotomy in a spinal injured population. J Urol 181:705–709PubMedCrossRef Pan D, Troy A, Rogerson J, Bolton D, Brown D, Lawrentschuk N (2009) Long-term outcomes of external sphincterotomy in a spinal injured population. J Urol 181:705–709PubMedCrossRef
49.
Zurück zum Zitat Takahashi R, Kimoto Y, Eto M (2018) Long-term urodynamic follow-up after external sphincterotomy in patients with spinal cord injury. Neurourol Urodyn 37:2625–2631PubMedCrossRef Takahashi R, Kimoto Y, Eto M (2018) Long-term urodynamic follow-up after external sphincterotomy in patients with spinal cord injury. Neurourol Urodyn 37:2625–2631PubMedCrossRef
50.
Zurück zum Zitat Ke QS, Kuo HC (2010) Transurethral incision of the bladder neck to treat bladder neck dysfunction and voiding dysfunction in patients with high-level spinal cord injuries. Neurourol Urodyn 29:748–752PubMedCrossRef Ke QS, Kuo HC (2010) Transurethral incision of the bladder neck to treat bladder neck dysfunction and voiding dysfunction in patients with high-level spinal cord injuries. Neurourol Urodyn 29:748–752PubMedCrossRef
51.
Zurück zum Zitat Vainrib M, Reyblat P, Ginsberg DA (2014) Long-term efficacy of repeat incisions of bladder neck/external sphincter in patients with spinal cord injury. Urology 84:940–945PubMedCrossRef Vainrib M, Reyblat P, Ginsberg DA (2014) Long-term efficacy of repeat incisions of bladder neck/external sphincter in patients with spinal cord injury. Urology 84:940–945PubMedCrossRef
52.
Zurück zum Zitat Chen SF, Jhang JF, Jiang YH, Kuo HC (2022) Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics. Int Urol Nephrol 54:1215–1223PubMedCrossRef Chen SF, Jhang JF, Jiang YH, Kuo HC (2022) Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics. Int Urol Nephrol 54:1215–1223PubMedCrossRef
53.
Zurück zum Zitat Lee KH, Kuo HC (2019) Recovery of voiding efficiency and bladder function in male patients with non-neurogenic detrusor underactivity after transurethral bladder outlet surgery. Urology 123:235–241PubMedCrossRef Lee KH, Kuo HC (2019) Recovery of voiding efficiency and bladder function in male patients with non-neurogenic detrusor underactivity after transurethral bladder outlet surgery. Urology 123:235–241PubMedCrossRef
54.
Zurück zum Zitat Lee CL, Jhang JF, Ho HC, Jiang YH, Hsu YH, Kuo HC (2022) Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification. Sci Rep 12:362PubMedPubMedCentralCrossRef Lee CL, Jhang JF, Ho HC, Jiang YH, Hsu YH, Kuo HC (2022) Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification. Sci Rep 12:362PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Chen JL, Kuo HC (2009) Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury. J Formos Med Assoc 108:475–480PubMedCrossRef Chen JL, Kuo HC (2009) Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury. J Formos Med Assoc 108:475–480PubMedCrossRef
56.
Zurück zum Zitat Kuo HC (1997) Clinical outcome and quality of life after enterocystoplasty for contracted bladders. Urol Int 58:160–165PubMedCrossRef Kuo HC (1997) Clinical outcome and quality of life after enterocystoplasty for contracted bladders. Urol Int 58:160–165PubMedCrossRef
57.
Zurück zum Zitat Gobeaux N, Yates DR, Denys P, Even-Schneider A, Richard F, Chartier-Kastler E (2012) Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results. Neurourol Urodyn 31:672–676PubMedCrossRef Gobeaux N, Yates DR, Denys P, Even-Schneider A, Richard F, Chartier-Kastler E (2012) Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results. Neurourol Urodyn 31:672–676PubMedCrossRef
58.
Zurück zum Zitat Stöhrer M, Kramer G, Goepel M, Löchner-Ernst D, Kruse D, Rübben H (1997) Bladder autoaugmentation in adult patients with neurogenic voiding dysfunction. Spinal Cord 35:456–462PubMedCrossRef Stöhrer M, Kramer G, Goepel M, Löchner-Ernst D, Kruse D, Rübben H (1997) Bladder autoaugmentation in adult patients with neurogenic voiding dysfunction. Spinal Cord 35:456–462PubMedCrossRef
59.
Zurück zum Zitat Skobejko-Wlodarska L, Strulak K, Nachulewicz P, Szymkiewicz C (1998) Bladder autoaugmentation in myelodysplastic children. Br J Urol 81(Suppl 3):114–116PubMedCrossRef Skobejko-Wlodarska L, Strulak K, Nachulewicz P, Szymkiewicz C (1998) Bladder autoaugmentation in myelodysplastic children. Br J Urol 81(Suppl 3):114–116PubMedCrossRef
60.
Zurück zum Zitat Pannek J, Wöllner J (2022) Management of stress urinary incontinence in female patients with spinal cord injury by autologous fascial sling: time for a revival? Spinal Cord Ser Cases 8:57PubMedPubMedCentralCrossRef Pannek J, Wöllner J (2022) Management of stress urinary incontinence in female patients with spinal cord injury by autologous fascial sling: time for a revival? Spinal Cord Ser Cases 8:57PubMedPubMedCentralCrossRef
61.
Zurück zum Zitat Abdullah A, Machkour F, Bouchet E, Plainard X, Descazeaud A (2019) Efficacy of the VIRTUE male quadratic sling in the treatment of stress urinary incontinence: a retrospective study. Prog Urol 29:490–495PubMedCrossRef Abdullah A, Machkour F, Bouchet E, Plainard X, Descazeaud A (2019) Efficacy of the VIRTUE male quadratic sling in the treatment of stress urinary incontinence: a retrospective study. Prog Urol 29:490–495PubMedCrossRef
62.
Zurück zum Zitat Deytrikh A, Downey AP, Mangera A, Reid SV (2022) Autologous fascial slings for stress urinary incontinence in patients with neuropathic bladder. Spinal Cord Ser Cases 8:25PubMedPubMedCentralCrossRef Deytrikh A, Downey AP, Mangera A, Reid SV (2022) Autologous fascial slings for stress urinary incontinence in patients with neuropathic bladder. Spinal Cord Ser Cases 8:25PubMedPubMedCentralCrossRef
63.
64.
Zurück zum Zitat Musco S, Ecclestone H, 't Hoen L, Blok BFM, Padilla-Fernández B, Del Popolo G, Groen J, Pannek J, Kessler TM, Karsenty G, Phé V, Sartori AM, Castro-Diaz D, Rizwan H (2022) Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review. Eur Urol Focus 8:1090-1102 Musco S, Ecclestone H, 't Hoen L, Blok BFM, Padilla-Fernández B, Del Popolo G, Groen J, Pannek J, Kessler TM, Karsenty G, Phé V, Sartori AM, Castro-Diaz D, Rizwan H (2022) Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review. Eur Urol Focus 8:1090-1102
65.
Zurück zum Zitat Farag F, Koens M, Sievert KD, De Ridder D, Feitz W, Heesakkers J (2016) Surgical treatment of neurogenic stress urinary incontinence: a systematic review of quality assessment and surgical outcomes. Neurourol Urodyn 35:21–25PubMedCrossRef Farag F, Koens M, Sievert KD, De Ridder D, Feitz W, Heesakkers J (2016) Surgical treatment of neurogenic stress urinary incontinence: a systematic review of quality assessment and surgical outcomes. Neurourol Urodyn 35:21–25PubMedCrossRef
66.
Zurück zum Zitat Krasmik D, Krebs J, van Ophoven A, Pannek J (2014) Urodynamic results, clinical efficacy, and complication rates of sacral intradural deafferentation and sacral anterior root stimulation in patients with neurogenic lower urinary tract dysfunction resulting from complete spinal cord injury. Neurourol Urodyn 33:1202–1206PubMedCrossRef Krasmik D, Krebs J, van Ophoven A, Pannek J (2014) Urodynamic results, clinical efficacy, and complication rates of sacral intradural deafferentation and sacral anterior root stimulation in patients with neurogenic lower urinary tract dysfunction resulting from complete spinal cord injury. Neurourol Urodyn 33:1202–1206PubMedCrossRef
67.
Zurück zum Zitat van Ophoven A, Engelberg S, Lilley H, Sievert KD (2021) Systematic literature review and meta-analysis of sacral neuromodulation (SNM) in patients with neurogenic lower urinary tract dysfunction (NLUTD): over 20 years’ experience and future directions. Adv Ther 38:1987–2006PubMedPubMedCentralCrossRef van Ophoven A, Engelberg S, Lilley H, Sievert KD (2021) Systematic literature review and meta-analysis of sacral neuromodulation (SNM) in patients with neurogenic lower urinary tract dysfunction (NLUTD): over 20 years’ experience and future directions. Adv Ther 38:1987–2006PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Kuo HC (1998) Quality of life after active urological management of chronic spinal cord injury in eastern Taiwan. Eur Urol 34:37–46PubMedCrossRef Kuo HC (1998) Quality of life after active urological management of chronic spinal cord injury in eastern Taiwan. Eur Urol 34:37–46PubMedCrossRef
69.
Zurück zum Zitat Wu SY, Kuo HC (2022) Satisfaction with surgical procedures and bladder management of chronic spinal cord injured patients with voiding dysfunction who desire spontaneous voiding. J Pers Med 12:1751PubMedPubMedCentralCrossRef Wu SY, Kuo HC (2022) Satisfaction with surgical procedures and bladder management of chronic spinal cord injured patients with voiding dysfunction who desire spontaneous voiding. J Pers Med 12:1751PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Stöhrer M, Madersbacher H, Richter R, Wehnert J, Dreikorn K (1999) Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia–a double-blind, placebo-controlled clinical trial. Spinal Cord 37:196–200PubMedCrossRef Stöhrer M, Madersbacher H, Richter R, Wehnert J, Dreikorn K (1999) Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia–a double-blind, placebo-controlled clinical trial. Spinal Cord 37:196–200PubMedCrossRef
71.
Zurück zum Zitat Hsu LN, Jhang JF, Ou YC, Chuang YC, Jang MY, Chin CW, Juan YS, Yang MH, Lin WY, Liu HH, Li JR, Kuo HC, and Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury – Part 4: Patient Risk, Bladder Management, and Active Surveillance. Urol Sci Jun 19. (Ahead of print publication) Hsu LN, Jhang JF, Ou YC, Chuang YC, Jang MY, Chin CW, Juan YS, Yang MH, Lin WY, Liu HH, Li JR, Kuo HC, and Taiwan Continence Society Spinal Cord Injury Study Group (2023) Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury – Part 4: Patient Risk, Bladder Management, and Active Surveillance. Urol Sci Jun 19. (Ahead of print publication)
Metadaten
Titel
Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan
verfasst von
Sheng-Fu Chen
Hann-Chorng Kuo
Publikationsdatum
30.11.2023
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2024
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03884-8

Weitere Artikel der Ausgabe 4/2024

International Urology and Nephrology 4/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.